BrainAurora Medical Technology Limited will convene its 2026 annual general meeting online on 18 June 2026 at 10:00 a.m. (Hong Kong time).

Key agenda items 1. Financial statements: Shareholders will vote on the adoption of the audited consolidated results for the year ended 31 December 2025 together with the directors’ and auditor’s reports. 2. Board composition: Five directors are standing for re-election—non-executive directors Deng Feng, Yang Fan and Wang Jingbo, and independent non-executive directors Dr. Duan Tao and Tu Lei. 3. Directors’ remuneration: Authority to set directors’ fees will be delegated to the board if approved. 4. Auditor: Deloitte Touche Tohmatsu is nominated for re-appointment, with the board empowered to determine its remuneration. 5. Capital mandates: • General share-issuance mandate—up to 20% of the issued share capital (excluding treasury shares). • Share repurchase mandate—up to 10% of the issued share capital (excluding treasury shares). • Extension mandate—any shares repurchased under the 10% buy-back authority will be added to the 20% issuance limit.

Proxy and voting logistics • Deadline for lodging proxy forms: 10:00 a.m. on 16 June 2026 (48 hours before the meeting). • Each share carries one vote; shareholders may appoint a proxy who is not required to be a shareholder. • Joint holders will receive a single set of log-in credentials for online participation.

The meeting will be held entirely through the Vistra eVoting Portal, and attendance via the portal will supersede any previous proxy instructions.